NasdaqCM - Nasdaq Real Time Price USD

Dogwood Therapeutics, Inc. (DWTX)

4.5600
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
4.6000
+0.04
+(0.88%)
After hours: May 9 at 7:25:22 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
12,227.2480
12,227.2480
5,446.9190
12,315.3090
15,640.9400
Operating Income
-12,227.2480
-12,227.2480
-5,446.9190
-12,315.3090
-15,640.9400
Net Non Operating Interest Income Expense
-92.1920
-92.1920
150.9040
67.4750
5.6720
Other Income Expense
-30.7870
-30.7870
--
--
-325
Pretax Income
-12,350.2270
-12,350.2270
-5,296.0150
-12,247.8340
-15,960.2680
Tax Provision
-0.5030
-0.5030
0
0
0
Net Income Common Stockholders
-12,349.7240
-12,349.7240
-5,296.0150
-12,247.8340
-15,960.2680
Diluted NI Available to Com Stockholders
-12,349.7240
-12,349.7240
-5,296.0150
-12,247.8340
-15,960.2680
Basic EPS
-12.52
--
-7.05
-27.75
-48.00
Diluted EPS
-12.52
--
-7.05
-27.75
-48.00
Basic Average Shares
1,027.7880
--
751.0710
442.8040
333.1720
Diluted Average Shares
1,027.7880
--
751.0710
442.8040
333.1720
Total Operating Income as Reported
-12,227.2480
-12,227.2480
-5,446.9190
-12,315.3090
-15,640.9400
Total Expenses
12,227.2480
12,227.2480
5,446.9190
12,315.3090
15,640.9400
Net Income from Continuing & Discontinued Operation
-12,349.7240
-12,349.7240
-5,296.0150
-12,247.8340
-15,960.2680
Normalized Income
-12,318.9383
-12,318.9383
-5,296.0150
-12,247.8340
-15,960.2680
Interest Income
--
--
150.9040
67.4750
--
Interest Expense
92.1920
92.1920
--
--
--
Net Interest Income
-92.1920
-92.1920
150.9040
67.4750
5.6720
EBIT
-12,258.0350
-12,258.0350
-5,446.9190
-12,315.3090
-15,640.9400
EBITDA
-12,245.8580
-12,245.8580
-5,446.9190
-12,315.3090
-15,640.9400
Reconciled Depreciation
12.1770
12.1770
0
--
--
Net Income from Continuing Operation Net Minority Interest
-12,349.7240
-12,349.7240
-5,296.0150
-12,247.8340
-15,960.2680
Total Unusual Items Excluding Goodwill
-30.7870
-30.7870
--
--
--
Total Unusual Items
-30.7870
-30.7870
--
--
--
Normalized EBITDA
-12,215.0710
-12,215.0710
-5,446.9190
-12,315.3090
-15,640.9400
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-0.0013
-0.0013
0
0
0
12/31/2021 - 12/17/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SLXN Silexion Therapeutics Corp
0.9848
-0.53%
 
OSRH OSR Holdings, Inc.
1.2500
-2.34%
 
TVGN Tevogen Bio Holdings Inc.
1.0900
0.00%
 
GLMD Galmed Pharmaceuticals Ltd.
1.2400
-0.80%
 
PSTV Plus Therapeutics, Inc.
0.6600
+6.45%
 
CRVO CervoMed Inc.
8.49
-4.61%
 
PHIO Phio Pharmaceuticals Corp.
1.7600
-2.22%
 
WINT Windtree Therapeutics, Inc.
0.8522
+0.39%
 
ENSC Ensysce Biosciences, Inc.
2.1700
+4.33%
 
PRTG Portage Biotech Inc.
8.18
-9.31%